GSA Capital Partners’s Guardant Health GH Stock Holding History

GSA Capital Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.77M	Buy	11,811 +7,211	+157%	+$784K	0.11%	213
2026 Q1	$425K	Buy	4,600 +72	+2%	+$7.23K	0.03%	1016
2025 Q4	$462K	Sell	4,528 -17,454	-79%	-$1.56M	0.04%	873
2025 Q3	$1.37M	Buy	21,982 +13,378	+155%	+$728K	0.11%	223
2025 Q2	$448K	Buy	+8,604	New	+$384K	0.03%	1004
2025 Q1	–	Sell	-25,180	Closed	-$769K	–	1810
2024 Q4	$769K	Buy	25,180 +8,691	+53%	+$244K	0.06%	587
2024 Q3	$378K	Sell	16,489 -2,510	-13%	-$71K	0.03%	1103
2024 Q2	$549K	Sell	18,999 -12,292	-39%	-$286K	0.04%	896
2024 Q1	$646K	Buy	31,291 +22,828	+270%	+$489K	0.05%	729
2023 Q4	$229K	Buy	+8,463	New	+$222K	0.02%	1250
2023 Q2	–	Sell	-14,508	Closed	-$340K	–	1649
2023 Q1	$340K	Buy	+14,508	New	+$414K	0.03%	950
2020 Q1	–	Sell	-8,989	Closed	-$702K	–	1237
2019 Q4	$702K	Buy	+8,989	New	+$648K	0.08%	423

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

GSA Capital Partners's GH Position: Q2 2026 in Review

GSA Capital Partners increased its Guardant Health (GH) stake by 157% in Q2 2026, buying an estimated $784K and bringing the position to 11,811 shares worth $1.77M. The position accounts for 0.11% of the portfolio, ranked #213.

GSA Capital Partners first reported a position in GH in Q4 2019 and has held it in 12 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

GSA Capital Partners held 11,811 shares of Guardant Health worth $1.77M as of Q2 2026.
GSA Capital Partners bought 7,211 Guardant Health shares in Q2 2026, an estimated $784K.
Guardant Health made up 0.11% of GSA Capital Partners's portfolio in Q2 2026, its #213 holding.
GSA Capital Partners first reported a position in Guardant Health in Q4 2019 and has held it in 12 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.